뉴스/소식 - Viva Pharmaceutical Inc.
Vancouver Sun columnist Malcolm Perry visited Viva Pharmaceutical Inc. for a feature on the Fairchild Group’s banquet-benefit for VGH and UBC Hospital Foundation, and an interview with Viva’s CEO Jason Ko took place. Viva Pharmaceutical showed their support of the Foundation by donating $1.2 million to fund a first-in-Canada demonstration project for the early detection and treatment of lung cancer using innovative screening strategy and advanced computer imaging.
Viva는 폐암의 조기발견 및 치료법 개발과 이미징 신기술을 연구하는 VGH와 UBC 병원 단체에 120만달러를 기부하였습니다.
The feature was released online on Friday, July 23, and was distributed in print on Saturday, July 24 (page F2).
Edit(Aug. 01): The feature was also realized on August 1st (page H2).
Edit (Aug. 02): The event was also covered by The Province on August 2nd.
On May 28, 2015, Minister Steven S.K.Chen, Minister of Overseas Community Affairs Council of ROC (Taiwan), visited Viva Pharmaceutical with the Consul General of ROC (Taiwan) in Vancouver, Mr. William Chuang alongside their delegates. The delegation attended a presentation on Viva and toured our facilities during their visit.
On May 20, Dr. Francis Ho, B.Sc., MD, CCFP, FCFP, Clinical Professor Emeritus of the Department of Family Practice, Faculty of Medicine at UBC and President/Board of Directors of the BC/Yukon Region of the Canadian Liver Foundation, visited Viva Pharmaceutical along with Monica Chui, Director of Regional Business Development in Western Canada and Mark Mansfield, Regional Manager of BC/Yukon. Viva Pharmaceutical showed their support of the Foundation by donating $10, 000 to the organization.
On May 8, Dr. David A.L. Maberley, MD, FRCSC, Professor and Head of the Department of Ophthalmology and Visual Sciences at UBC, Department Head of Ophthalmology at Vancouver Acute, Regional Department Head of Ophthalmology as VCH and PHC, visited Viva. Dr. Maberley met with Viva to explore opportunities to research potential collaborations as well as toured Viva’s plant facility. Viva looks forward to further relations with Dr. David A.L Maberley; stay tuned for more updates.